Cspc Pharmaceutical | 1093 - Beneficio Bruto En Ventas

Precio De Mercado
9.26
Cambio Diario
0.15 1.65%
Mensual
2.21%
Anual
75.71%
Q2 Expectativa
9.48




Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Jiangsu Hengrui CNY 6.36B 1.15B 2025-09
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Sh Fosun Pharma CNY 4.8B 93.72M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Wuxi Apptec CNY 6.12B 958.48M 2025-09
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06